HeyJaredDominic Giannini
- Indexed articles, last 90 days
- 4
- Latest publication
- Sep 29, 2026
- Outlet visibility, for Politico Europe
- Top 50K sites
- Earliest in this view
- Aug 23, 2026
Latest articles
Gastein health conference gets underway (opens the original)
Read excerpt
Want to receive this newsletter straight to your inbox? Sign up here to receive the reporting and intel from the Gastein Health Forum. — Clemens Martin Auer, president of the European Health Forum Gastein, calls for more action ahead of a four-day health conference. — The health committee wants action on rare diseases and cancer, as watered-down wording over alcohol spurred controversy. — U.S. tariffs of up to 100% on pharmaceuticals and their ingredients are set to kick in. Welcome to Tuesday’s
Ozempic-maker turns to Anthropic to turbocharge medical research (opens the original)
Read excerpt
Novo and Anthropic announced a collaboration Wednesday to accelerate the development of new medicines and AI-driven software. The news landed hours after European Commission President Ursula von der Leyen spoke about the benefits of AI in health care — and days after tech bros warned there is a 10% likely existential threat to all humanity from super AI within the next decade. Anthopic also revealed last week scientists have tried to use Claude to develop bioweapons. The Danish pharma giant said
Rich countries face Covid-related costs for 20 more years, says OECD (opens the original)
Read excerpt
The health and economic impacts from Covid-19 will likely continue for another two decades, according to a report out Tuesday from the world’s wealthiest countries. The pandemic saw rates of smoking, drinking alcohol and unhealthy eating rise, while care for people with chronic diseases was interrupted. All of which continues to add pressure to today's economies and health systems, the Organisation for Economic Co-operation and Development said in its report. And while countries continue to feel
Tiny fish could unlock new MS drugs. Brexit is getting in the way. (opens the original)
Read excerpt
EDINBURGH — Scotland suffers from blistering rates of multiple sclerosis, and Edinburgh says the difficulty in getting visas post-Brexit is stifling cutting-edge scientific research. Scientists at the University of Edinburgh are at the forefront of MS research with tiny fish that can regenerate their nervous system. But with the U.K. no longer in the EU, barriers to working with the best and brightest experts are causing bottlenecks for breakthroughs. “Ten years ago, we could have a killer scien
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 50K sites
For Politico Europe, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.